As of September 29, 2026, Aprea Therapeutics's top three insider holders are Oren Gilad (President/Ceo, 393.89K shares), Marc Duey (Director, 259.29K shares), Bernd R. Seizinger (Director, 48.91K shares).
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Oren Gilad | President/Ceo | 393,895 | 0 | 393,895 | 47.9% | 16 Mar, 2026 |
| 2 | Marc Duey | Director | 259,290 | 0 | 259,290 | 31.5% | 17 Jun, 2026 |
| 3 | Bernd R. Seizinger | Director | 48,910 | 0 | 48,910 | 5.9% | 17 Jun, 2026 |
| 4 | John P. Hamill | Srvp/Cfo/Prin Fin Acct Ofcr | 43,528 | 0 | 43,528 | 5.3% | 16 Mar, 2026 |
| 5 | John B Iii Henneman | Director | 13,364 | 0 | 13,364 | 1.6% | 17 Jun, 2026 |
| 6 | Christian S Schade | Chairman Ceo | 12,962 | 0 | 12,962 | 1.6% | 01 Aug, 2022 |
| 7 | Rifat Pamukcu | Director | 8,581 | 0 | 8,581 | 1.0% | 17 Jun, 2026 |
| 8 | Scott M Coiante | Svp, Chief Financial Officer | 7,253 | 0 | 7,253 | 0.9% | 01 Aug, 2022 |
| 9 | Nadeem Q. Mirza | Chief Medical Officer | 6,730 | 0 | 6,730 | 0.8% | 02 May, 2024 |
| 10 | Richard Peters | Director | 6,254 | 0 | 6,254 | 0.8% | 17 Jun, 2026 |
| 11 | Michael Grissinger | Director | 6,024 | 0 | 6,024 | 0.7% | 17 Jun, 2026 |
| 12 | Gabriela Gruia | Director | 4,180 | 0 | 4,180 | 0.5% | 17 Jun, 2026 |
| 13 | Jean-Pierre Bizzari | Director | 4,180 | 0 | 4,180 | 0.5% | 17 Jun, 2026 |
| 14 | Eyal C. Attar | Svp, Chief Medical Officer | 2,862 | 0 | 2,862 | 0.3% | 07 Jun, 2022 |
| 15 | Gregory Alan Korbel | Svp, Chief Operating Officer | 2,288 | 0 | 2,288 | 0.3% | 01 Aug, 2022 |
| 16 | Lars B. Abrahmsen | Svp, Chief Scientific Officer | 2,185 | 0 | 2,185 | 0.3% | 14 Mar, 2022 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 16 Jun, 2026 | Marc Duey | Director | Acquired A | 3,135 | $0.00 | $0 | 259,290 | Direct |
| 16 Jun, 2026 | Rifat Pamukcu | Director | Acquired A | 3,135 | $0.00 | $0 | 8,581 | Direct |
| 16 Jun, 2026 | Gabriela Gruia | Director | Acquired A | 3,135 | $0.00 | $0 | 4,180 | Direct |
| 16 Jun, 2026 | Bernd R. Seizinger | Director | Acquired A | 3,135 | $0.00 | $0 | 48,910 | Direct |
| 16 Jun, 2026 | Michael Grissinger | Director | Acquired A | 3,135 | $0.00 | $0 | 6,024 | Direct |
| 16 Jun, 2026 | Richard Peters | Director | Acquired A | 3,135 | $0.00 | $0 | 6,254 | Direct |
| 16 Jun, 2026 | Jean-Pierre Bizzari | Director | Acquired A | 3,135 | $0.00 | $0 | 4,180 | Direct |
| 16 Jun, 2026 | John B Iii Henneman | Director | Acquired A | 3,135 | $0.00 | $0 | 13,364 | Direct |
| 16 Jun, 2026 | Michael Grissinger | Director | Acquired A | 12,555 | $0.00 | $0 | 12,555 | Direct |
| 16 Jun, 2026 | Bernd R. Seizinger | Director | Acquired A | 12,555 | $0.00 | $0 | 12,555 | Direct |
| 16 Jun, 2026 | Gabriela Gruia | Director | Acquired A | 12,555 | $0.00 | $0 | 12,555 | Direct |
| 16 Jun, 2026 | Richard Peters | Director | Acquired A | 12,555 | $0.00 | $0 | 12,555 | Direct |
| 16 Jun, 2026 | Jean-Pierre Bizzari | Director | Acquired A | 12,555 | $0.00 | $0 | 12,555 | Direct |
| 16 Jun, 2026 | John B Iii Henneman | Director | Acquired A | 12,555 | $0.00 | $0 | 12,555 | Direct |
| 16 Jun, 2026 | Marc Duey | Director | Acquired A | 12,555 | $0.00 | $0 | 12,555 | Direct |
| 16 Jun, 2026 | Rifat Pamukcu | Director | Acquired A | 12,555 | $0.00 | $0 | 12,555 | Direct |
| 31 Mar, 2026 | Richard Peters | Director | Acquired P | 123,915 | $0.81 | $100.00K | 123,915 | Direct |
| 31 Mar, 2026 | John P. Hamill | Srvp/Cfo/Prin Fin Acct Ofcr | Acquired P | 30,978 | $0.81 | $25.00K | 30,978 | Direct |
| 31 Mar, 2026 | John P. Hamill | Srvp/Cfo/Prin Fin Acct Ofcr | Acquired P | 30,978 | — | — | 30,978 | Direct |
| 31 Mar, 2026 | Richard Peters | Director | Acquired P | 123,915 | — | — | 123,915 | Direct |